University of Michigan: Sclerosis trials

The registry lists 18 Sclerosis studies with University of Michigan as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 1 2Phase 2 1Phase 4 1No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis FatigueCompletedNCT03621761Phase 4Results posted
• Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)CompletedNCT03274076Phase 1/2Results posted
• Taking Charge of Systemic SclerosisCompletedNCT02494401Not applicableResults posted
• A P300 Brain Computer Interface Keyboard to Control Assistive Technology For Use by People With Amyotrophic Lateral SclerosisCompletedNCT01119001Not applicableResults posted
• Optimizing Detection and Prediction of Changes in Cognitive Function in Multiple Sclerosis (MS)Active, not recruitingNCT05252195
• Mechanistic Study of OcrevusCompletedNCT04459988
• PTNS on Urinary and Global Quality of Life in MS PatientsCompletedNCT04063852
• My MS Toolkit: a Symptom Self-management Program for Multiple SclerosisCompletedNCT03708276Not applicable
• A Pilot Study of the Utility of 3D Printed Masks for ALS SubjectsTerminatedNCT03519880Not applicable
• Rehabilitation for Arm Coordination and Hand Movement in Systemic SclerosisCompletedNCT03482219Not applicable
• Mechanistic Studies of Teriflunomide in RRMSCompletedNCT03464448
• Effects of Inspiratory Muscle Training in Persons With Advanced Multiple SclerosisCompletedNCT03345199Not applicable
• Therapeutic Imaging Biomarkers for Amyotrophic Lateral SclerosisTerminatedNCT02058732Not applicable
• Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)TerminatedNCT02000713Not applicable
• Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00809224
• Angiogenic/Angiostatic Mediators in Patients With Systemic SclerosisCompletedNCT00668473
• Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic SclerosisCompletedNCT00667134
• Trial of Early Noninvasive Ventilation for Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00580593Phase 1